Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

BRENDA Home
show all | hide all No of entries

Information on EC 3.4.24.16 - neurolysin and Organism(s) Rattus norvegicus and UniProt Accession P42676

for references in articles please use BRENDA:EC3.4.24.16
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
     3 Hydrolases
         3.4 Acting on peptide bonds (peptidases)
             3.4.24 Metalloendopeptidases
                3.4.24.16 neurolysin
Specify your search results
Select one or more organisms in this record: ?
This record set is specific for:
Rattus norvegicus
UNIPROT: P42676 not found.
Show additional data
Do not include text mining results
Include (text mining) results
Include results (AMENDA + additional results, but less precise)
Word Map
The taxonomic range for the selected organisms is: Rattus norvegicus
The expected taxonomic range for this enzyme is: Eukaryota, Bacteria
Reaction Schemes
Preferential cleavage in neurotensin: Pro10-/-Tyr
Synonyms
neurolysin, ep24.16, endopeptidase 24.16, ep 24.16, mitochondrial peptidase, oligopeptidase m, soluble angiotensin-binding protein, microsomal endopeptidase, soluble angiotensin ii-binding protein, neurotensin endopeptidase, more
SYNONYM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
endopeptidase 3.4.24.16
-
neurotensin-cleaving enzyme
-
endopeptidase 24.16
endopeptidase 24.16B
-
-
-
-
MEP
-
-
-
-
Microsomal endopeptidase
MOP
-
-
-
-
neurolisin
-
-
neurotensin endopeptidase
-
-
-
-
oligopeptidase M
peptidase, neurotensin endo
-
-
-
-
peptidase, neurotensin endo-
-
-
-
-
SABP
-
-
-
-
soluble angiotensin II-binding protein
-
-
Soluble angiotensin-binding protein
-
-
-
-
thimet oligopeptidase II
-
neurolysin is most likely to be confused with thimet oligopeptidase II, but it is distinguished by its lack of activation by thiol compounds, inhibition by millimolar concentrations of Pro-Ile, cleavage of neurotensin at the Pro-Tyr bond, and different mobility in column chromatography
thimet peptidase II
-
-
additional information
CAS REGISTRY NUMBER
COMMENTARY hide
149371-24-4
-
90463-53-9
-
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
2-aminobenzoyl-dynorphin A(1-8)-N-(2,4-dinitrophenyl)-ethylenediamine + H2O
?
show the reaction diagram
binding structure and conformational effects on the enzyme compared to inhibitor R2
-
-
?
2-aminobenzoyl-neurotensin-N-(2,4-dinitrophenyl)-ethylenediamine + H2O
?
show the reaction diagram
binding structure and conformational effects on the enzyme compared to inhibitor R2
-
-
?
angiotensin I + H2O
?
show the reaction diagram
-
-
-
?
bradykinin + H2O
?
show the reaction diagram
-
-
-
?
Mcc-Pro-Leu-Gly-Pro-D-Lys(Dnp) + H2O
?
show the reaction diagram
substrate QFS
-
-
?
Neuromedin B + H2O
?
show the reaction diagram
-
-
-
?
neurotensin + H2O
?
show the reaction diagram
orexin B + H2O
?
show the reaction diagram
-
-
-
?
somatostatin + H2O
?
show the reaction diagram
-
-
-
?
urocortin + H2O
?
show the reaction diagram
-
-
-
?
(7-methoxy-coumarin-4-yl)acetyl-RPKPVE-Nva-WRK(2,4-dinitrophenyl)-NH2 + H2O
(7-methoxy-coumarin-4-yl)acetyl-RPKP + YA-Nva-WMK(2,4-dinitrophenyl)-NH2
show the reaction diagram
-
substrate of matrix metalloproteinases MMP3
cleavage at the peptide bond between proline and tyrosine, withabout 1/10 efficiency in wild-type compared with the cleavage of the MMPs-2/9-specific peptide (7-methoxy-coumarin-4-yl)acetyl-RPKPYA-Nva-WMK(2,4-dinitrophenyl)-NH2
-
?
(7-methoxy-coumarin-4-yl)acetyl-RPKPYA-Nva-WMK(2,4-dinitrophenyl)-NH2 + H2O
(7-methoxy-coumarin-4-yl)acetyl-RPKP + YA-Nva-WMK(2,4-dinitrophenyl)-NH2
show the reaction diagram
-
substrate of matrix metalloproteinases MMP-2/-9
cleavage at the peptide bond between proline and tyrosine
-
?
(7-methoxycoumarin-4-yl)acetyl-Gly-Gly-Phe-Ile-Arg-Arg-Ala-Lys-dinitrophenyl + H2O
(7-methoxycoumarin-4-yl)acetyl-Gly-Gly-Phe-Ile-Arg-Arg + Ala-Lys-dinitrophenyl
show the reaction diagram
(7-methoxycoumarin-4-yl)acetyl-Gly-Gly-Phe-Leu-Arg-Arg-Ala-Lys-dinitrophenyl + H2O
peptide fragments
show the reaction diagram
-
i.e. QF34, cleavage sites: Leu4-Arg5, Arg5-Arg6
-
-
?
7-methoxycoumarin-3-carboxylyl-Pro-Leu-Gly-Pro-Lys-dinitrophenyl + H2O
?
show the reaction diagram
-
-
-
-
?
7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl) + H2O
?
show the reaction diagram
-
-
-
?
Abz-GDSPFRQ-EDDnp + H2O
Abz-GDSP + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GESPFRQ-EDDnp + H2O
Abz-GESP + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GFSAFRQ-EDDnp + H2O
Abz-GFSA + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GFSEFRQ-EDDnp + H2O
Abz-GFSE + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GFSFFRQ-EDDnp + H2O
Abz-GFSF + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GFSHFRQ-EDDnp + H2O
Abz-GFSH + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GFSIFRQ-EDDnp + H2O
Abz-GFSI + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GFSLFRQ-EDDnp + H2O
Abz-GFSL + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GFSPFRQ-EDDnp + H2O
Abz-GFSP + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GFSQFRQ-EDDnp + H2O
Abz-GFSQ + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GFSRFRQ-EDDnp + H2O
Abz-GFSR + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GFSSFRQ-EDDnp + H2O
Abz-GFSS + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GFSWFRQ-EDDnp + H2O
Abz-GFSW + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GFSYFRQ-EDDnp + H2O
Abz-GFSY + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GGSPFRQEDDnp + H2O
Abz-GGSP + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
Abz-GPSPFRQ-EDDnp + H2O
Abz-GPSP + FRQ-EDDnp
show the reaction diagram
-
-
-
-
?
acetyl-Arg-Arg-Pro-Tyr-Ile-Leu + H2O
acetyl-Arg-Arg-Pro + Tyr-Ile-Leu
show the reaction diagram
-
i.e. acetyneurotensin(8-13)
-
?
Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys + H2O
?
show the reaction diagram
-
i.e. somatostatin, cleavage sites: Phe6-Phe7, Thr10-Phe11
-
-
?
angiotensin I + H2O
?
show the reaction diagram
-
-
-
?
angiotensin II + H2O
?
show the reaction diagram
-
-
-
?
Arg-Arg-Pro-Tyr-Ile-Leu + H2O
Arg-Arg-Pro + Tyr-Ile-Leu
show the reaction diagram
-
-
-
-
?
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 + H2O
Arg-Pro-Lys-Pro-Gln + Gln-Phe-Phe-Gly-Leu-Met-NH2 + Arg-Pro-Lys-Pro-Gln-Gln + Phe-Phe-Gly-Leu-Met-NH2 + Arg-Pro-Lys-Pro
show the reaction diagram
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe + H2O
Asp-Arg-Val-Tyr + Ile-His-Pro-Phe
show the reaction diagram
-
i.e. angiotensin II
-
?
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu + H2O
Asp-Arg-Val-Tyr-Ile-His-Pro + Phe-His-Leu
show the reaction diagram
-
-
-
-
?
bradykinin + H2O
?
show the reaction diagram
DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS + H2O
?
show the reaction diagram
-
-
-
-
?
dinitrophenyl-Pro-Leu-Gly-Pro-Trp-D-Lys + H2O
peptide fragments
show the reaction diagram
-
-
-
-
?
dynorphin A(1-17) + H2O
?
show the reaction diagram
-
-
-
-
?
dynorphin A1-13 + H2O
?
show the reaction diagram
-
-
-
?
Luteinizing hormone-releasing hormone + H2O
?
show the reaction diagram
-
-
-
-
?
LVVYPWTQRY + H2O
?
show the reaction diagram
-
cleavage sites: LVVYP-/-W-/-T-/-Q-/-RY
-
?
neurotensin + H2O
?
show the reaction diagram
pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu + H2O
pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro + Tyr-Ile-Leu
show the reaction diagram
PVNFKFLSH + H2O
?
show the reaction diagram
-
cleavage sites: PVNF-/-K-/-F-/-LSH
-
?
Pz-Pro-Leu-Gly-Pro-D-Arg + H2O
?
show the reaction diagram
-
-
-
-
?
Tyr-Gly-Gly-Phe-Leu-Arg + H2O
Tyr-Gly-Gly-Phe + Leu-Arg
show the reaction diagram
-
-
-
?
Tyr-Gly-Gly-Phe-Leu-Arg-Arg + H2O
?
show the reaction diagram
-
cleavage sites: Phe4-Leu5, Leu5-Arg6
-
-
?
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile + H2O
?
show the reaction diagram
-
cleavage sites: Leu-5-Arg6, Arg6-Arg7
-
-
?
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile + H2O
Tyr-Gly-Gly-Phe-Leu + Arg-Arg-Ile
show the reaction diagram
-
-
-
-
?
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg + H2O
Tyr-Gly-Gly-Phe-Leu-Arg-Arg + Ile-Arg
show the reaction diagram
-
-
-
?
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln + H2O
peptide fragments
show the reaction diagram
VVYPWTQRY + H2O
?
show the reaction diagram
-
cleavage sites: VVYPW-/-T-/-Q-/-RY
-
?
[(7-methoxycoumarin-4-yl)acetyl]-APAKFFRLK(Dnp)-NH2 + H2O
[(7-methoxycoumarin-4-yl)acetyl]-APAK + FFRLK(Dnp)-NH2
show the reaction diagram
-
best substrate
-
-
?
[(7-methoxycoumarin-4-yl)acetyl]-DEVDAPK(Dnp)-NH2 + H2O
?
show the reaction diagram
-
very low activity
-
-
?
[(7-methoxycoumarin-4-yl)acetyl]-GKPILFFRLK(Dnp)DR-NH2 + H2O
[(7-methoxycoumarin-4-yl)acetyl]-GKP + ILFFRLK(Dnp)DR-NH2
show the reaction diagram
-
high activity
-
-
?
[(7-methoxycoumarin-4-yl)acetyl]-GKPILFFRLK(Dnp)DR-NH2 + H2O
[(7-methoxycoumarin-4-yl)acetyl]-GKPIL + FFRLK(Dnp)DR-NH2
show the reaction diagram
-
high activity
-
-
?
[(7-methoxycoumarin-4-yl)acetyl]-GSPAFLAK(Dnp)DR-NH2 + H2O
[(7-methoxycoumarin-4-yl)acetyl]-GSPA + FLAK(Dnp)DR-NH2
show the reaction diagram
-
low activity
-
-
?
[(7-methoxycoumarin-4-yl)acetyl]-RPKPYANvaWMK(Dnp)-NH2 + H2O
?
show the reaction diagram
-
a substrate of MMP-2 and MMP-9
-
-
?
[(7-methoxycoumarin-4-yl)acetyl]-RPKPYANvaWMK(Dnp)-NH2 + H2O
[(7-methoxycoumarin-4-yl)acetyl]-RPKP + YANvaWMK(Dnp)-NH2
show the reaction diagram
-
high activity
-
-
?
[(7-methoxycoumarin-4-yl)acetyl]-RPKPYANvaWMK(Dnp)-NH2 + H2O
[(7-methoxycoumarin-4-yl)acetyl]-RPKPY + ANvaWMK(Dnp)-NH2
show the reaction diagram
-
high activity
-
-
?
[(7-methoxycoumarin-4-yl)acetyl]-RPPGFSAFK(Dnp)-OH + H2O
?
show the reaction diagram
-
-
-
-
?
[(7-methoxycoumarin-4-yl)acetyl]-RPPGFSAFK(Dnp)-OH + H2O
[(7-methoxycoumarin-4-yl)acetyl]-RPPGFSA + FK(Dnp)-OH
show the reaction diagram
-
low activity
-
-
?
additional information
?
-
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
Neuromedin B + H2O
?
show the reaction diagram
-
-
-
?
neurotensin + H2O
?
show the reaction diagram
secreted neuropeptide
-
-
?
orexin B + H2O
?
show the reaction diagram
-
-
-
?
somatostatin + H2O
?
show the reaction diagram
-
-
-
?
urocortin + H2O
?
show the reaction diagram
-
-
-
?
neurotensin + H2O
?
show the reaction diagram
additional information
?
-
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
Zinc
-
zinc metalloprotease
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
1-adamantan-2-yl-3-[2-[2,3-bis-(2-chloro-phenyl)-pyrazolidin-1-yl]-2-oxo-ethyl]-urea
racemic
3-[(2S)-1-[(3R)-3-(2-chlorophenyl)-2-(2-fluorophenyl)pyrazolidin-1-yl]-1-oxopropan-2-yl]-1-(adamantan-2-yl)urea
R-stereomer, allosteric inhibition of neurolysin, mixed-type inhibition kinetics, the bound inhibitor disrupts activity by preventing a hinge-like motion associated with substrate binding and catalysis. The inhibitor reverses a substrate-associated conformational change
Mcc-Pro-Leu
Nln-mediated hydrolysis of QFS yields a degradation product that triggers a relatively product inhibition
Pro-L-PhePsi(PO2CH2)Gly-Pro
-
(2R)-2-[(4-biphenylylsulfonyl)amino]-3-phenylpropionic acid
-
-
(2R)-[(4-biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide
-
-
1,10-phenanthroline
3-(4-phenoxyphenylsulfonyl)-propylthiirane
-
-
acetyl-neurotensin(8-13)
acetyl-neurotensin(8-13)aminde
-
degradation of tritiated neurotensin
agaricoglyceride A
-
main active principle of the crude extract of Agaricus macrosporus shows strong activity against neurolysin
agaricoglyceride B
-
agaricoglyceride C, agaricoglyceride D, known cometabolites agaricic ester show no activity against neurolysin up to 0.01 mM
alpha-melanotrophin-stimulating hormone
-
weak
angiotensin I
angiotensin II
Arg-Pro-Pro
-
-
bombesin
-
weak
bradykinin
carboxy-2-phenylethyl-Ala-Ala-Phe-4-aminobenzoate
-
-
carboxyphenylethyl-Ala-Ala-Phe-4-aminobenzoate
carboxyphenylethyl-Ala-Ala-Tyr-4-aminobenzoate
-
-
dithiothreitol
-
-
dynorphin A(1-13)
-
-
dynorphin A1-13
-
inhibits hydrolysis of 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl)
dynorphin(1-8)
-
degradation of 3-carboxy-7-methoxycoumaryl-Pro-Leu-Gly-Pro-D-Lys-dinitrophenyl
dynorphin(1-9)
-
degradation of 3-carboxy-7-methoxycoumaryl-Pro-Leu-Gly-Pro-D-Lys-dinitrophenyl
H-Cys1-Thr-Thr-His-Trp-Gly-Phe-Thr-Leu-Cys10-OH
-
-
HONHCO-CH2-CH(CH2-C6H5)CO-Ile-Ala
-
potent and selective inhibitor of neurolysin
JA-2
-
i.e. N-[1-(R,S)-carboxy-3-phenylpropyl]Ala-Aib-Tyrp-aminobenzoate, the aromatic ring of Tyr605 was an important anchor for its interaction with wild-type TOP
kinetensin
-
degradation of 3-carboxy-7-methoxycoumaryl-Pro-Leu-Gly-Pro-D-Lys-dinitrophenyl
-
LVVYPWTQRY
-
inhibits hydrolysis of 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl)
N-(1(R,S)-carboxy-3-phenylpropyl)-Ala-Ala-Tyr-p-aminobenzoate
-
inhibits EP24.16 resulting in a 1000fold increase in type-2 BK receptor sensitivity to bradykinin as measured by inositol phosphate accumulation
N-(phenylethylphosphonyl)-Gly-L-Pro-L-aminohexanoic acid
-
-
N-(phenylethylphosphonyl)-Gly-Pro-L-norleucine
-
-
N-[1-(RS)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-4-aminobenzoate
-
-
N-[1-(RS)-carboxy-3-phenylpropyl]-Ala-Ala-Tyr-4-aminobenzoate
-
-
N-[1-(RS)-carboxy-3-phenylpropyl]-Ala-Pro-Phe-4-aminobenzoate
-
-
Neuromedin N
neurotensin
neurotensin(8-13)
-
degradation of tritiated neurotensin
neurotensin(9-13)
Pro-DL-Phe-Psi(PO2CH2)-Gly-Pro-NH2
-
-
Pro-Ile
Pro-Phe-PSI(PO2CH2)Gly-Pro
-
potent and selective inhibitor of neurolysin
Pro-Phe-PSI(PO2CH2)Leu-Pro-NH2
-
potent and selective inhibitor of neurolysin
Pro-Xaa dipeptides
-
most potent inhibitors, Xaa-Pro dipeptides are ineffective
PVNFKFLSH
-
inhibits hydrolysis of 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl)
Somatostatin
-
weak
Substance P
Tuftsin
-
weak
VVYPWTQRY
-
inhibits hydrolysis of 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl)
Xenopsin
[acetylPhe12]neurotensin(8-13)
-
degradation of tritiated neurotensin
[Ala12]neurotensin(8-13)
-
degradation of tritiated neurotensin
[Ala13]neurotensin(8-13)
-
degradation of tritiated neurotensin
[D-Arg8]neurotensin(8-13)
-
degradation of tritiated neurotensin
[D-Arg9]neurotensin(8-13)
-
degradation of tritiated neurotensin
[D-Leu11]neurotensin
-
degradation of tritiated neurotensin
[D-Phe11]neurotensin
-
degradation of tritiated neurotensin
[D-Trp11]neurotensin
-
degradation of tritiated neurotensin
[D-Tyr11]neurotensin
-
degradation of tritiated neurotensin
[D-Tyr3]neurotensin
-
degradation of tritiated neurotensin
[Dopa11]neurotensin
-
degradation of tritiated neurotensin
[His11]neurotensin
-
degradation of tritiated neurotensin
[naphthylalanyl11]neurotensin(8-13)
-
degradation of tritiated neurotensin
[Phe11]neurotensin
-
degradation of tritiated neurotensin
[Ser11]neurotensin(8-13)
-
degradation of tritiated neurotensin
[Thr11]neurotensin
-
degradation of tritiated neurotensin
[Trp11]neurotensin
-
degradation of tritiated neurotensin
[Tyr-ethyl ester11]neurotensin(8-13)
-
degradation of tritiated neurotensin
[Tyr13]neurotensin(8-13)
-
degradation of tritiated neurotensin
additional information
-
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
thiols
-
activate
additional information
-
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
6 - 14
(7-methoxy-coumarin-4-yl)acetyl-RPKPVE-Nva-WRK(2,4-dinitrophenyl)-NH2
7.7 - 19
(7-methoxy-coumarin-4-yl)acetyl-RPKPYA-Nva-WMK(2,4-dinitrophenyl)-NH2
0.002 - 0.0022
(7-methoxycoumarin-4-yl)acetyl-Gly-Gly-Phe-Ile-Arg-Arg-Ala-Lys-dinitrophenyl
0.0043
(7-methoxycoumarin-4-yl)acetyl-Gly-Gly-Phe-Leu-Arg-Arg-Ala-Lys-dinitrophenyl
-
-
0.0006 - 0.0031
2-aminobenzoyl-GFSPFRQ-(N-2,4-dinitrophenyl)ethylenediamine
0.0498
7-methoxycoumarin-3-carboxylyl-Pro-Leu-Gly-Pro-Lys-dinitrophenyl
0.0009 - 0.0078
Abz-GFSAFRQEDDnp
0.0024 - 0.0053
Abz-GFSEFRQEDDnp
0.0015 - 0.0101
Abz-GFSFFRQEDDnp
0.0018 - 0.0106
Abz-GFSHFRQEDDnp
0.0008 - 0.0048
Abz-GFSIFRQEDDnp
0.0018 - 0.0061
Abz-GFSLFRQEDDnp
0.0016 - 0.021
Abz-GFSQFRQEDDnp
0.0008 - 0.0083
Abz-GFSRFRQEDDnp
0.0056 - 0.0111
Abz-GFSSFRQEDDnp
0.0008 - 0.006
Abz-GFSWFRQEDDnp
0.0012 - 0.0096
Abz-GFSyFRQEDDnp
0.05
dinitrophenyl-Pro-Leu-Gly-Pro-Trp-D-Lys
-
-
0.002 - 0.00295
neurotensin
0.085
Tyr-Gly-Gly-Phe-Leu-Arg
-
-
0.041
Tyr-Gly-Gly-Phe-Leu-Arg-Arg
-
-
0.007
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile
-
-
0.013
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg
-
-
additional information
additional information
-
Km-values for the reaction with angiotensin I analogs
-
TURNOVER NUMBER [1/s]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.76 - 1.1
(7-methoxy-coumarin-4-yl)acetyl-RPKPVE-Nva-WRK(2,4-dinitrophenyl)-NH2
1.9 - 2.1
(7-methoxy-coumarin-4-yl)acetyl-RPKPYA-Nva-WMK(2,4-dinitrophenyl)-NH2
11.9
(7-methoxycoumarin-4-yl)acetyl-Gly-Gly-Phe-Ile-Arg-Arg-Ala-Lys-dinitrophenyl
-
-
2.1
(7-methoxycoumarin-4-yl)acetyl-Gly-Gly-Phe-Leu-Arg-Arg-Ala-Lys-dinitrophenyl
-
-
0.006 - 0.3
2-aminobenzoyl-GFSPFRQ-(N-2,4-dinitrophenyl)ethylenediamine
0.2 - 2.6
Abz-GFSAFRQEDDnp
0.1 - 1.2
Abz-GFSEFRQEDDnp
0.09 - 4.9
Abz-GFSFFRQEDDnp
0.05 - 6.3
Abz-GFSHFRQEDDnp
0.01 - 0.2
Abz-GFSIFRQEDDnp
0.1 - 3.5
Abz-GFSLFRQEDDnp
0.6 - 5.9
Abz-GFSQFRQEDDnp
0.4 - 4.8
Abz-GFSRFRQEDDnp
0.06 - 7.5
Abz-GFSSFRQEDDnp
0.3 - 2.4
Abz-GFSWFRQEDDnp
0.3 - 4.1
Abz-GFSyFRQEDDnp
2.8 - 5
neurotensin
0.827
Tyr-Gly-Gly-Phe-Leu-Arg
-
-
1.94
Tyr-Gly-Gly-Phe-Leu-Arg-Arg
-
-
2.52
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile
-
-
1.5
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg
-
-
additional information
additional information
-
turnover-numbers for the reaction with angiotensin I analogs
-
Ki VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.00535
angiotensin I
-
inhibition of hydrolysis of 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl)
0.00795
angiotensin II
-
inhibition of hydrolysis of 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl)
0.00811
bradykinin
-
inhibition of hydrolysis of 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl)
0.000022
dynorphin A1-13
-
inhibition of hydrolysis of 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl)
0.00201
LVVYPWTQRY
-
inhibition of hydrolysis of 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl)
0.00343
PVNFKFLSH
-
inhibition of hydrolysis of 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl)
0.00704
VVYPWTQRY
-
inhibition of hydrolysis of 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl)
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.0066
1-adamantan-2-yl-3-[2-[2,3-bis-(2-chloro-phenyl)-pyrazolidin-1-yl]-2-oxo-ethyl]-urea
Rattus norvegicus
pH 7.5, 37°C
0.0075
3-[(2S)-1-[(3R)-3-(2-chlorophenyl)-2-(2-fluorophenyl)pyrazolidin-1-yl]-1-oxopropan-2-yl]-1-(adamantan-2-yl)urea
Rattus norvegicus
pH 7.5, 37°C
SPECIFIC ACTIVITY [µmol/min/mg]
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
additional information
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
7.5
-
assay at
7.5 - 7.6
-
-
pH RANGE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
additional information
-
pH-dependence of wild-type and mutant enzymes, overview
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
primary cultured cells
Manually annotated by BRENDA team
additional information
-
no activity in the duodenum
Manually annotated by BRENDA team
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
evolution
the enzyme belongs to the M3 metallopeptidase family
physiological function
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION?
NEUL_RAT
704
0
80254
Swiss-Prot
Mitochondrion (Reliability: 1)
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
66000 - 70000
-
gel filtration
70000
-
1 * 70000, SDS-PAGE
70000 - 75000
-
gel filtration
75000
-
1 * 75000, SDS-PAGE
80202
-
x * 80202, calculation from nucleotide sequence
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
?
x * 75000, recombinant His6-tagged enzyme, SDS-PAGE
?
-
x * 80202, calculation from nucleotide sequence
monomer
additional information
POSTTRANSLATIONAL MODIFICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
no modification
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
purified enzyme with bound inhibitor R2, hanging drop vapor diffusion, mixing 2 ml of 48 mM protein in the presence of 5fold stoichiometric excess of inhibitor R2 with 1 ml of well solution containing 0.1 M HEPES, pH 7.0, 0.1 M LiSO4,2 mM 2-mercaptoethanol, and 12-15% PEG 4000, 4°C, X-ray diffraction structure determination and analysis at 2.8 A resolution
crystal structure analysis and comparisons, overview
-
purified recombinant mutant R470E/T499R, hanging drop vapour diffusion method, 4°C, 0.001 ml of 10 mg/ml protein is mixed with 0.001 ml of well solution containing 100 mM sodium cacodylate, pH 6.5, 100 mM magnesium acetate, 2 mM 2-mercaptoethanol, and 12-14% w/v polyethylene glycol 6000, cryoprotection by 25% glycerol, X-ray diffraction structure determination and analysis at 2.2 A resolution
-
recombinant enzyme from Escherichia coli, hanging-drop vapor-diffusion method
-
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
E475A
site-directed mutagenesis, mutation of the catalytic glutamate residue, a catalytically compromised enzyme mutant that sediments more rapidly in the presence of saturating amounts of the dynorphin A(1-8) substrate compared to the wild-type enzyme
H160A
site-directed mutagenesis, mutation of a surface histidine involved in a divalent cation-mediated lattice contact in the original neurolysin crystals
606A
-
a cleavage site mutant with altered substrate specificity
E502A
-
complete loss of enzymatic activity
G608A
-
site-directed mutagenesis, the mutation does not affect the overall fold of the protein, the mutant shows altered substrate specificity and kinetics with fluorogenic peptide substrates compared to the wild-type enzyme
H473A
-
complete loss of enzymatic activity
H474A
-
complete loss of enzymatic activity
H477A
-
complete loss of enzymatic activity
R470E/T499R
-
site-directed mutagenesis of the substrate recognition residues leads to a swap of substrate specificity from thimet oligopeptidase to neurolysin, EC 3.4.24.16, the mutant cleaves neurolysin sites, overview
Y606A
-
site-directed mutagenesis, the mutation does not affect the overall fold of the protein, the mutant shows altered substrate specificity and kinetics with fluorogenic peptide substrates compared to the wild-type enzyme
Y606F
Y610L
-
marked change in substrate specificity with 3fold higher binding efficiency to matrix metalloproteinase MMP-2/9 substrate (7-methoxy-coumarin-4-yl)acetyl-RPKPYA-Nva-WMK(2,4-dinitrophenyl)-NH2 with glutamic acid at the P2' amino acid position
GENERAL STABILITY
ORGANISM
UNIPROT
LITERATURE
up to two cycles of freezing and thawing of the purified rNln do not significantly affect the purified recombinant enzyme's specific activity
0.001 mM Zn2+ stabilizes
-
STORAGE STABILITY
ORGANISM
UNIPROT
LITERATURE
a gradual decrease of the specific activity is observed in preparations kept longer than 6 months at -80°C
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
recombinant His6-tagged enzyme from Escherichia coli by nickel affinity chromatography, ultrafiltration, and gel filtration to homogeneity, large scale production of rNln
recombinant GST-tagged wild-type and mutant enzymes from Escherichia coli strain DH5alpha by glutathione affinity chromatography to homogeneity
-
recombinant wild-type and mutant enzymes from Escherichia coli strain Bl21(DE3)
-
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
recombinant enzyme expression in Escherichia coli
recombinant expression of N-terminally His6-tagged enzyme in Escherichia coli
enzyme cloning from isolated ciliary body and liver, expression analysis
-
exhibits 60.2% homology with EC 3.4.24.15
-
expression of GST-tagged wild-type and mutant enzymes in Escherichia coli strain DH5alpha
-
expression of neurolysin gene fron brain ligated to the C-terminal half of the alpha-agglutinin gene with a FLAG tag sequence in Saccharomyces cerevisiae at the cell surface, construction of a molecular displaying plasmid
-
expression of the FLAG-tagged brain enzyme in Saccharomyces cerevisiae strain BJ2168 on the cell surface, subcloning in Escherichia coli strain DH5alpha
-
expression of wild-type and mutant enzymes in Escherichia coli strain BL21(DE3)
-
overexpressed in human kidney cells, HK293 cells. The transfectants exhibit a membrane-associated form of endopeptidase-24.16, the catalytic site of which clearly faces the extracellular domain. Transfected cells are unable to secrete the enzyme
-
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
molecular biology
-
neurolysin can be used as a molecular tool for analysis of properties of cancer-producing matrix metalloproteinases MMP-2 and MMP-9, quantitative determination of cleavage activity of neurolysin toward MMPspecific fluorescence-quenching peptides, overview
additional information
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Dahms, P.; Mentlein, R.
Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16
Eur. J. Biochem.
208
145-154
1992
Rattus norvegicus, Sus scrofa
Manually annotated by BRENDA team
Barrett, A.J.; Brown, M.A.; Dando, P.M.; Knight, C.G.; McKie, N.; Rawlings, N.D.; Serizawa, A.
Thimet oligopeptidase and oligopeptidase M or neurolysin
Methods Enzymol.
248
529-556
1995
Rattus norvegicus
Manually annotated by BRENDA team
Checler, F.; Vincent, J.P.; Kitabgi, P.
Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes
J. Biol. Chem.
261
11274-11281
1986
Rattus norvegicus
Manually annotated by BRENDA team
Checler, F.; Barelli, H.; Vincent, J.P.
Tissue distribution of a novel neurotensin-degrading metallopeptidase. An immunological approach using monospecific polyclonal antibodies
Biochem. J.
257
549-554
1989
Rattus norvegicus
Manually annotated by BRENDA team
Barelli, H.; Vincent, J.P.; Checler, F.
Peripheral inactivation of neurotensin. Isolation and characterization of a metallopeptidase from rat ileum
Eur. J. Biochem.
175
481-489
1988
Rattus norvegicus
Manually annotated by BRENDA team
Rodd, D.; Hersh, L.B.
Endopeptidase 24.16B. A new variant of endopeptidase 24.16
J. Biol. Chem.
270
10056-10061
1995
Rattus norvegicus
Manually annotated by BRENDA team
Dauch, P.; Vincent, J.P.; Checler, F.
Specific inhibition of endopeptidase 24.16 by dipeptides
Eur. J. Biochem.
202
269-276
1991
Rattus norvegicus
Manually annotated by BRENDA team
Checler, F.; Barelli, H.; Dauch, P.; Vincent, B.; Dive, V.; Beaudet, A.; Daniel, E.E.; Fox-Threlkeld, J.E.T.; Masuo, Y.; Vincent, J.P.
Recent advances on endopeptidase-3.4.24.16
Biochem. Soc. Trans.
21
692-697
1993
Rattus norvegicus
Manually annotated by BRENDA team
Mentlein, R.; Dahms, P.
Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes
J. Neurochem.
62
27-36
1994
Rattus norvegicus
Manually annotated by BRENDA team
Vincent, B.; Dauch, P.; Vincent J.P.; Checler, F.
Stably transfected human cells overexpressing rat brain endopeptidase 3.4.24.16: biochemical characterization of the activity and expression of soluble and membrane-associated counterparts
J. Neurochem.
68
837-845
1997
Rattus norvegicus
Manually annotated by BRENDA team
Serizawa, A.; Dando, P.M.; Barrett, A.J.
Characterization of a mitochondrial metallopeptidase reveals neurolysin as a homologue of thimet oligopeptidase
J. Biol. Chem.
276
2092-2098
1995
Rattus norvegicus
Manually annotated by BRENDA team
Dauch, P.; Vincent, J.P.; Checler, F.
Molecular cloning and expression of rat brain endopeptidase 3.4.24.16
J. Biol. Chem.
270
27266-27271
1995
Rattus norvegicus
Manually annotated by BRENDA team
Barelli, H.; Vincent, J.P.; Checler, F.
Rat kidney endopeptidase 24.16. Purification, physico-chemical characteristics and differential specificity towards opiates, tachykinins and neurotensin-related peptides
Eur. J. Biochem.
211
79-90
1993
Rattus norvegicus
Manually annotated by BRENDA team
Lian, W.; Chen, G.; Wu, D.; Brown, C.K.; Madauss, K.; Hersh, L.B.; Rodgers, D.W.
Crystallization and preliminary analysis of neurolysin
Acta Crystallogr. Sect. D
56
1644-1646
2000
Rattus norvegicus
-
Manually annotated by BRENDA team
Rioli, V.; Gozzo, F.C.; Heimann, A.S.; Linardi, A.; Krieger, J.E.; Shida, C.S.; Almeida, P.C.; Hyslop, S.; Eberlin, M.N.; Ferro, E.S.
Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme
J. Biol. Chem.
278
8547-8555
2003
Rattus norvegicus
Manually annotated by BRENDA team
Barrett, A.J.; Dando, P.M.
Neurolysin
Handbook of Proteolytic Enzymes(Barrett,A. J. ,Rawlings,N. D. ,Woessner,J. F. ,Eds. )Academic Press
1
356-360
2004
Oryctolagus cuniculus, Homo sapiens, Mus musculus, Rattus norvegicus, Sus scrofa
-
Manually annotated by BRENDA team
Stadler, M.; Hellwig, V.; Mayer-Bartschmid, A.; Denzer, D.; Wiese, B.; Burkhardt, N.
Novel analgesic triglycerides from cultures of Agaricus macrosporus and other basidiomycetes as selective inhibitors of neurolysin
J. Antibiot.
58
775-786
2005
Rattus norvegicus
Manually annotated by BRENDA team
Jeske, N.A.; Berg, K.A.; Cousins, J.C.; Ferro, E.S.; Clarke, W.P.; Glucksman, M.J.; Roberts, J.L.
Modulation of bradykinin signaling by EP24.15 and EP24.16 in cultured trigeminal ganglia
J. Neurochem.
97
13-21
2006
Rattus norvegicus
Manually annotated by BRENDA team
Kadonosono, T.; Kato, M.; Ueda, M.
Metallopeptidase, neurolysin, as a novel molecular tool for analysis of properties of cancer-producing matrix metalloproteinases-2 and -9
Appl. Microbiol. Biotechnol.
75
1285-1291
2007
Rattus norvegicus
Manually annotated by BRENDA team
Kadonosono, T.; Kato, M.; Ueda, M.
Substrate specificity of rat brain neurolysin disclosed by molecular display system and putative substrates in rat tissues
Appl. Microbiol. Biotechnol.
75
1353-1360
2007
Rattus norvegicus
Manually annotated by BRENDA team
Machado, M.F.; Rioli, V.; Dalio, F.M.; Castro, L.M.; Juliano, M.A.; Tersariol, I.L.; Ferro, E.S.; Juliano, L.; Oliveira, V.
The role of Tyr605 and Ala607 of thimet oligopeptidase and Tyr606 and Gly608 of neurolysin in substrate hydrolysis and inhibitor binding
Biochem. J.
404
279-288
2007
Rattus norvegicus
Manually annotated by BRENDA team
Bertazolli-Filho, R.; Coca-Prados, M.; Haddad, A.; Laicine, E.M.
Molecular analysis of neurolysin expression in the rat and bovine ciliary body
Curr. Eye Res.
32
751-756
2007
Bos taurus, Rattus norvegicus
Manually annotated by BRENDA team
Lim, E.J.; Sampath, S.; Coll-Rodriguez, J.; Schmidt, J.; Ray, K.; Rodgers, D.W.
Swapping the substrate specificities of the neuropeptidases neurolysin and thimet oligopeptidase
J. Biol. Chem.
282
9722-9732
2007
Rattus norvegicus
Manually annotated by BRENDA team
Kadonosono, T.; Kato-Murai, M.; Ueda, M.
Alteration of substrate specificity of rat neurolysin from matrix metalloproteinase-2/9-type to -3-type specificity by comprehensive mutation
Protein Eng. Des. Sel.
21
507-513
2008
Rattus norvegicus
Manually annotated by BRENDA team
Lorenzon, R.Z.; Cunha, C.E.; Marcondes, M.F.; Machado, M.F.; Juliano, M.A.; Oliveira, V.; Travassos, L.R.; Paschoalin, T.; Carmona, A.K.
Kinetic characterization of the Escherichia coli oligopeptidase A (OpdA) and the role of the Tyr(607) residue
Arch. Biochem. Biophys.
500
131-136
2010
Rattus norvegicus
Manually annotated by BRENDA team
Swindle, J.D.; Santos, K.L.; Speth, R.C.
Pharmacological characterization of a novel non-AT1, non-AT2 angiotensin binding site identified as neurolysin
Endocrine
44
525-531
2013
Rattus norvegicus (P42676), Rattus norvegicus Sprague-Dawley (P42676)
Manually annotated by BRENDA team
Hines, C.S.; Ray, K.; Schmidt, J.J.; Xiong, F.; Feenstra, R.W.; Pras-Raves, M.; de Moes, J.P.; Lange, J.H.; Melikishvili, M.; Fried, M.G.; Mortenson, P.; Charlton, M.; Patel, Y.; Courtney, S.M.; Kruse, C.G.; Rodgers, D.W.
Allosteric inhibition of the neuropeptidase neurolysin
J. Biol. Chem.
289
35605-35619
2014
Rattus norvegicus (P42676)
Manually annotated by BRENDA team
Wangler, N.J.; Jayaraman, S.; Zhu, R.; Mechref, Y.; Abbruscato, T.J.; Bickel, U.; Karamyan, V.T.
Preparation and preliminary characterization of recombinant neurolysin for in vivo studies
J. Biotechnol.
234
105-115
2016
Rattus norvegicus (P42676)
Manually annotated by BRENDA team
Checler, F.; Ferro, E.S.
Neurolysin from initial detection to latest advances
Neurochem. Res.
43
2017-2024
2018
Bos taurus (A2VDQ5), Rattus norvegicus (P42676), Sus scrofa (Q02038), Mus musculus (Q91YP2), Homo sapiens (Q9BYT8), Mus musculus C57BL6 (Q91YP2)
Manually annotated by BRENDA team